Research Article| Volume 97, ISSUE 2, P251-256, November 2004

Download started.


Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension


      Background: Hypertension is associated with changes in concentrations of vasoactive peptides and procollagen propeptides, but their relationships with left ventricular hypertrophy and cardiac function are unclear. Methods: We measured plasma levels of atrial natriuretic peptide (ANP), its amino terminal propeptide (NT-proANP), B-type natriuretic peptide (BNP), endothelin-1 (ET-1), and serum levels of the aminoterminal propeptide of type I procollagen (PINP) and the aminoterminal propeptide of type III procollagen (PIIINP) and echocardiographic parameters in 97 patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial. Results: Median values (reference values) of the peptides were: ANP 11.2 (6.9–14.9) pmol/l, NT-proANP 351 (143–311) pmol/l, BNP 1.1 (0.4–7.2) pmol/l, ET-1 8.7 (1.2–5.0) pmol/l, PIIINP 2.8 (1.7–4.2) μg/l and PINP 29 (19–84) μg/l. Plasma BNP levels in patients with left ventricular hypertrophy (1.2 pmol/l) and patients with echocardiographic signs of diastolic dysfunction (1.5 pmol/l) were greater than those in patients without hypertrophy (0.7 pmol/l) and normal diastolic parameters (0.9 pmol/l) (p<0.05). BNP was the only biochemical parameter that independently predicted interventricular septal diastolic diameter (p<0.05), left ventricular mass index (p<0.01) and ratio of the velocity–time integrals of the E and A waves of the mitral inflow in a stepwise logistic regression analysis (p<0.05). Conclusions: The results show that BNP reflects the remodelling process in hypertension.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Weber K.T.
        • Sun Y.
        • Tyagi S.C.
        • Cleutjens J.P.M.
        Collagen network of the myocardium: function, structural remodeling and regulatory mechanism.
        J. Mol. Cell. Cardiol. 1994; 26: 279-292
        • Lorell B.H.
        • Carabello B.A.
        Left ventricular hypertrophy. Pathogenesis, detection and prognosis.
        Circulation. 2000; 102: 470-479
        • European Study Group on Diastolic Heart Failure
        How to diagnose diastolic heart failure.
        Eur. Heart J. 1998; 19: 990-1003
        • Ruskoaho H.
        Atrial natriuretic peptide: synthesis, release, and metabolism.
        Pharmacol. Rev. 1992; 44: 479-602
        • Levin E.R.
        • Gardner D.G.
        • Samson W.K.
        Natriuretic peptides.
        N. Engl. J. Med. 1998; 339: 321-328
        • Kohno M.
        • Horio T.
        • Yokokawa K.
        • et al.
        Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
        Am. J. Med. 1995; 98: 257-265
        • Nishikimi T.
        • Yoshihara F.
        • Morimoto A.
        • et al.
        Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
        Hypertension. 1996; 28: 22-30
        • Yamamoto K.
        • Burnett Jr., J.C.
        • Jougasaki M.
        • et al.
        Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
        Hypertension. 1996; 28: 988-994
        • Talwar S.
        • Siebenhofer A.
        • Williams B.
        • Ngo L.
        Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP.
        Heart. 2000; 83: 278-282
        • Iivanainen A.M.
        • Tikkanen I.
        • Tilvis R.
        • Heikkilä J.
        • Helenius T.
        • Kupari M.
        Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample.
        J. Int. Med. 1997; 241: 261-268
        • Schirmer H.
        • Omland T.
        Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population.
        Eur. Heart J. 1999; 20: 755-763
        • Dessı̀-Fulgheri P.
        • Palermo R.
        • Di Noto G.
        • et al.
        High levels of plasma atrial natriuretic factor and impaired left ventricular diastolic function in hypertensives without left ventricular hypertrophy.
        J. Hypertens. 1992; 10: 161-165
        • Pontremoli R.
        • Bezante G.P.
        • Robaudo C.
        • et al.
        Cardiac diastolic abnormalities and atrial natriuretic factor in essential hypertension.
        Eur. Heart J. 1993; 14: 910-914
        • Lang C.C.
        • Prasad N.
        • McAlpine H.M.
        • et al.
        Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction.
        Am. Heart J. 1994; 127: 1635-1636
        • Krishnaswamy P.
        • Lubien E.
        • Clopton P.
        • et al.
        Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction.
        Am. J. Med. 2001; 111: 274-279
        • Lubien E.
        • DeMaria A.
        • Krishnaswamy P.
        • et al.
        Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings.
        Circulation. 2002; 105: 595-601
        • Tamura N.
        • Ogawa Y.
        • Chusho H.
        • et al.
        Cardiac fibrosis in mice lacking brain natriuretic peptide.
        Proc. Natl. Acad. Sci. 2000; 97: 4239-4244
        • Hua L.
        • Li C.
        • Xia D.
        • et al.
        Relationships between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide.
        Hypertens. Res. 2000; 23: 377-380
        • Iwanaga Y.
        • Kihara Y.
        • Hasegawa K.
        • et al.
        Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.
        Circulation. 1998; 98: 2065-2073
        • Uusimaa P.
        • Risteli J.
        • Niemelä M.
        • et al.
        Collagen scar formation after acute myocardial infarction. Relationships to infarct size, left ventricular function and coronary artery patency.
        Circulation. 1997; 96: 2565-2572
        • Dı́ez J.
        • Laviades C.
        • Mayor G.
        • Gil M.J.
        • Monreal I.
        Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
        Circulation. 1995; 91: 1450-1456
        • López B.
        • Querejeta R.
        • Varo N.
        • et al.
        Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.
        Circulation. 2001; 104: 286-291
        • Sever P.S.
        • Dahlöff B.
        • Puoulter N.R.
        • et al.
        • for the ASCOT investigators
        Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial.
        J. Hypertens. 2001; 19: 1139-1147
        • Uusimaa P.
        • Tokola H.
        • Ruskoaho H.
        • et al.
        Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
        J. Hum. Hypertens. 2001; 15: S19-S22
        • Devereux R.B.
        • Reichek N.
        Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
        Circulation. 1977; 55: 613-618
        • Thürman P.A.
        • Kenedi P.
        • Schmidt A.
        • Harder S.
        • Rietbrock N.
        Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
        Circulation. 1998; 98: 2037-2042
        • Vuolteenaho O.
        • Arjamaa O.
        • Ling N.
        Atrial natriuretic polypeptide (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25–35 amino acids.
        Biochem. Biophys. Res. Commun. 1985; 129: 82-88
        • Uusimaa P.
        • Ruskoaho H.
        • Vuolteenaho O.
        • et al.
        Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction.
        Int. J. Cardiol. 1999; 69: 5-14
        • Risteli J.
        • Niemi S.
        • Trived P.
        • Mowat A.P.
        • Risteli L.
        Rapid equilibrium radioimmmunoassay for the aminoterminal propeptide of human type III procollagen.
        Clin. Chem. 1988; 34: 715-718
        • Melkko J.
        • Kauppila S.
        • Niemi S.
        • et al.
        Immunoassay for intact amino-terminal propeptide of human type I procollagen.
        Clin. Chem. 1996; 42: 947-954
        • Yu C.M.
        • Sanderson J.E.
        • Shum I.O.L.
        • et al.
        Diastolic dyfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
        Eur. Heart J. 1996; 17: 1694-1702
        • Sayama H.
        • Nakamura Y.
        • Saito N.
        • Kinoshita M.
        Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?.
        Coron. Artery Dis. 1999; 10: 537-540
        • Palmieri V.
        • Dahlöf B.
        • DeQuattro V.
        • et al.
        Reliability of echocardiographic assessment of left ventricular structure and function. The PRESERVE Study.
        J. Am. Coll. Cardiol. 1999; 34: 1625-1632
        • De Simone G.
        • Devereux R.B.
        • Koren M.J.
        • Mensah G.A.
        • Casale P.N.
        • Laragh J.H.
        Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension.
        Circulation. 1996; 93: 259-265